LCM
VANI icon

Lazari Capital Management’s Vivani Medical VANI Stock Holding History

Lazari Capital Management’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.4K Hold
10,000
– – ﹤0.01% 187
2026
Q1 		$10K Hold
10,000
– – ﹤0.01% 174
2025
Q4 		$12.3K Hold
10,000
– – ﹤0.01% 165
2025
Q3 		$14.1K Hold
10,000
– – ﹤0.01% 166
2025
Q2 		$12.9K Hold
10,000
– – ﹤0.01% 154
2025
Q1 		$10.5K Hold
10,000
– – ﹤0.01% 152
2024
Q4 		$11.6K Hold
10,000
– – ﹤0.01% 148
2024
Q3 		$11.7K Buy
+10,000
New +$12.5K 0.01% 154

Other funds holding VANI

TWM
Tanager Wealth Management Goring On Thames, United Kingdom $1.15B AUM 19.91% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.64B AUM 19.37% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Lazari Capital Management's VANI Position: Q2 2026 in Review

Lazari Capital Management held its Vivani Medical (VANI) position steady in Q2 2026 at 10,000 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #187.

Lazari Capital Management first reported a position in VANI in Q3 2024 and has held it in 8 quarters since. The position peaked at $14.1K in Q3 2025. 7 funds tracked by Wall St. Rank hold VANI as of Q2 2026.

  • Lazari Capital Management held 10,000 shares of Vivani Medical worth $12.4K as of Q2 2026.
  • Lazari Capital Management left its Vivani Medical share count unchanged in Q2 2026.
  • Vivani Medical made up ﹤0.01% of Lazari Capital Management's portfolio in Q2 2026, its #187 holding.
  • Lazari Capital Management first reported a position in Vivani Medical in Q3 2024 and has held it in 8 quarters since.
  • Lazari Capital Management's Vivani Medical position peaked at $14.1K in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Vivani Medical as of Q2 2026.

Based on Lazari Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.